A citation-based method for searching scientific literature

Melissa K Frey, Sarah S Lee, Deanna Gerber, Zachary P Schwartz, Jessica Martineau, Kathleen Lutz, Erin Reese, Emily Dalton, Annie Olsen, Julia Girdler, Bhavana Pothuri, Leslie Boyd, John P Curtin, Douglas A Levine, Stephanie V Blank. Gynecol Oncol 2020
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity





Uptake rates for breast cancer genetic testing: a systematic review.
Mary E Ropka, Jennifer Wenzel, Elayne K Phillips, Mir Siadaty, John T Philbrick. Cancer Epidemiol Biomarkers Prev 2006
112
100

Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
Hayley S Thompson, Heiddis B Valdimarsdottir, Chantal Duteau-Buck, Josephine Guevarra, Dana H Bovbjerg, Cassandra Richmond-Avellaneda, David Amarel, Diana Godfrey, Karen Brown, Kenneth Offit. Cancer Epidemiol Biomarkers Prev 2002
116
100

Genetic counseling referral for ovarian cancer patients: a call to action.
Christine Garcia, Kara Harrison, Kari L Ring, Mackenzie W Sullivan, Lisa A Rauh, Susan C Modesitt. Fam Cancer 2019
3
100

Patterns and predictors of genetic referral among ovarian cancer patients at a National Cancer Institute-Comprehensive Cancer Center.
Adrianne R Mallen, Claire C Conley, Mary K Townsend, Ali Wells, Bernadette M Boac, Sarah Todd, Anjalika Gandhi, Michelle Kuznicki, Bianca M Augusto, McKenzie McIntyre,[...]. Clin Genet 2020
3
100

Oncologist-led BRCA 'mainstreaming' in the ovarian cancer clinic: A study of 255 patients and its impact on their management.
Megan Rumford, Mark Lythgoe, Iain McNeish, Hani Gabra, Laura Tookman, Nazneen Rahman, Angela George, Jonathan Krell. Sci Rep 2020
4
100

Genetic counseling globally: Where are we now?
Kelly E Ormond, Mercy Ygoña Laurino, Kristine Barlow-Stewart, Tina-Marié Wessels, Shelley Macaulay, Jehannine Austin, Anna Middleton. Am J Med Genet C Semin Med Genet 2018
44
100

Mainstreamed genetic testing for women with ovarian cancer: first-year experience.
Belinda Rahman, Anne Lanceley, Rebecca S Kristeleit, Jonathan A Ledermann, Michelle Lockley, Mary McCormack, Tim Mould, Lucy Side. J Med Genet 2019
20
100

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.
Gordon Guyatt, Andrew D Oxman, Elie A Akl, Regina Kunz, Gunn Vist, Jan Brozek, Susan Norris, Yngve Falck-Ytter, Paul Glasziou, Hans DeBeer,[...]. J Clin Epidemiol 2011
100

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
824
100

Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
Leslie M Randall, Bhavana Pothuri, Elizabeth M Swisher, John P Diaz, Adam Buchanan, Catherine T Witkop, C Bethan Powell, Ellen Blair Smith, Mark E Robson, Jeff Boyd,[...]. Gynecol Oncol 2017
52
100

Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study.
Kelly A Metcalfe, Isabel Fan, John McLaughlin, Harvey A Risch, Barry Rosen, Joan Murphy, Linda Bradley, Susan Armel, Ping Sun, Steven A Narod. Gynecol Oncol 2009
45
100

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
107
100

The development and evaluation of a nationwide training program for oncology health professionals in the provision of genetic testing for ovarian cancer patients.
M Gleeson, M Kentwell, B Meiser, J Do, S Nevin, N Taylor, K Barlow-Stewart, J Kirk, P James, C L Scott,[...]. Gynecol Oncol 2020
4
100

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline Summary.
Panagiotis A Konstantinopoulos, Christina Lacchetti, Christina M Annunziata. JCO Oncol Pract 2020
8
100

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
100

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.
Susan M Domchek, Tara M Friebel, Susan L Neuhausen, Theresa Wagner, Gareth Evans, Claudine Isaacs, Judy E Garber, Mary B Daly, Rosalind Eeles, Ellen Matloff,[...]. Lancet Oncol 2006
210
100

Development and testing of the health care system distrust scale.
Abigail Rose, Nikki Peters, Judy A Shea, Katrina Armstrong. J Gen Intern Med 2004
129
100

Disparities in gynecologic cancer genetics evaluation.
Emily M Hinchcliff, Erica M Bednar, Karen H Lu, J Alejandro Rauh-Hain. Gynecol Oncol 2019
23
100

NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
Mary B Daly, Robert Pilarski, Matthew B Yurgelun, Michael P Berry, Saundra S Buys, Patricia Dickson, Susan M Domchek, Ahmed Elkhanany, Susan Friedman, Judy E Garber,[...]. J Natl Compr Canc Netw 2020
93
100

Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals.
Terri Febbraro, Katina Robison, Jennifer Scalia Wilbur, Jessica Laprise, Amy Bregar, Vrishali Lopes, Robert Legare, Ashley Stuckey. Gynecol Oncol 2015
60
100

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
665
100

Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data.
Zachary Munn, Sandeep Moola, Karolina Lisy, Dagmara Riitano, Catalin Tufanaru. Int J Evid Based Healthc 2015
408
100

Large, Prospective Analysis of the Reasons Patients Do Not Pursue BRCA Genetic Testing Following Genetic Counseling.
Sommer Hayden, Sarah Mange, Debra Duquette, Nancie Petrucelli, Victoria M Raymond. J Genet Couns 2017
22
100

The Time for Mainstreaming Germline Testing for Patients With Breast Cancer Is Now.
Padma Sheila Rajagopal, Daniel V T Catenacci, Olufunmilayo I Olopade. J Clin Oncol 2019
4
100

Direct Genetics Referral Pathway for High-Grade Serous Ovarian Cancer Patients: The "Opt-Out" Process.
Jacob McGee, Teresa M Peart, Norine Foley, Monique Bertrand, Michel Prefontaine, Akira Sugimoto, Helen Ettler, Stephen Welch, Karen Panabaker. J Oncol 2019
5
100

Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
Maira Kentwell, Eryn Dow, Yoland Antill, C David Wrede, Orla McNally, Emily Higgs, Anne Hamilton, Sumitra Ananda, Geoffrey J Lindeman, Clare L Scott. Gynecol Oncol 2017
54
100

Men's decision-making about predictive BRCA1/2 testing: the role of family.
N Hallowell, A Ardern-Jones, R Eeles, C Foster, A Lucassen, C Moynihan, M Watson. J Genet Couns 2005
54
100

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer.
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, Mary Putt. JAMA 2005
281
100


Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based care.
Leigha Senter, David M O'Malley, Floor J Backes, Larry J Copeland, Jeffery M Fowler, Ritu Salani, David E Cohn. Gynecol Oncol 2017
21
100

Factors associated with decisions about clinical BRCA1/2 testing.
K Armstrong, K Calzone, J Stopfer, G Fitzgerald, J Coyne, B Weber. Cancer Epidemiol Biomarkers Prev 2000
102
100

Genetic Testing and Results in a Population-Based Cohort of Breast Cancer Patients and Ovarian Cancer Patients.
Allison W Kurian, Kevin C Ward, Nadia Howlader, Dennis Deapen, Ann S Hamilton, Angela Mariotto, Daniel Miller, Lynne S Penberthy, Steven J Katz. J Clin Oncol 2019
90
100

Universal Tumor DNA BRCA1/2 Testing of Ovarian Cancer: Prescreening PARPi Treatment and Genetic Predisposition.
Janet R Vos, Ingrid E Fakkert, Joanne A de Hullu, Anne M van Altena, Aisha S Sie, Hicham Ouchene, Riki W Willems, Iris D Nagtegaal, Marjolijn C J Jongmans, Arjen R Mensenkamp,[...]. J Natl Cancer Inst 2020
11
100

Factors associated with referral and completion of genetic counseling in women with epithelial ovarian cancer.
Stephanie Alimena, Lauren Scarpetti, Erica L Blouch, Linda Rodgers, Kristen Shannon, Marcela Del Carmen, Annekathryn Goodman, Whitfield B Growdon, Eric Eisenhauer, Rachel Clark Sisodia. Int J Gynecol Cancer 2020
1
100

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. BMJ 2009
100

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake,[...]. Proc Natl Acad Sci U S A 2011
564
100

Disparities in genetics assessment for women with ovarian cancer: Can we do better?
Erica Manrriquez, Jocelyn S Chapman, Julie Mak, Amie M Blanco, Lee-May Chen. Gynecol Oncol 2018
22
100

Factors associated with an individual's decision to withdraw from genetic testing for breast and ovarian cancer susceptibility: implications for counseling.
Béatrice Godard, Annabelle Pratte, Martine Dumont, Adèle Simard-Lebrun, Jacques Simard. Genet Test 2007
32
100

Increasing genetic counseling referral rates through bundled interventions after ovarian cancer diagnosis.
Casey L Swanson, Amanika Kumar, Joy M Maharaj, Jennifer L Kemppainen, Brittany C Thomas, Megan R Weinhold, Kristine M Slaby, Kristin C Mara, Myra J Wick, Jamie N Bakkum-Gamez. Gynecol Oncol 2018
13
100


Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.
Jacqueline Mersch, Michelle A Jackson, Minjeong Park, Denise Nebgen, Susan K Peterson, Claire Singletary, Banu K Arun, Jennifer K Litton. Cancer 2015
248
100

Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities.
Larissa A Meyer, Meaghan E Anderson, Robin A Lacour, Anuj Suri, Molly S Daniels, Diana L Urbauer, Graciela M Nogueras-Gonzalez, Kathleen M Schmeler, David M Gershenson, Karen H Lu. Obstet Gynecol 2010
80
100

The association between race and attitudes about predictive genetic testing.
Nikki Peters, Abigail Rose, Katrina Armstrong. Cancer Epidemiol Biomarkers Prev 2004
88
100

The role of financial factors in acceptance of clinical BRCA genetic testing.
Shannon Kieran, Lois J Loescher, Kyung Hee Lim. Genet Test 2007
32
100

Video-assisted genetic counseling in patients with ovarian, fallopian and peritoneal carcinoma.
Catherine H Watson, Michael Ulm, Patrick Blackburn, Linda Smiley, Mark Reed, Rachel Covington, Lauren Bokovitz, Todd Tillmanns. Gynecol Oncol 2016
7
100

Referral of Ovarian Cancer Patients for Genetic Counselling by Oncologists: Need for Improvement.
Maria Teresa Ricci, Stefania Sciallero, Serafina Mammoliti, Viviana Gismondi, Marzena Franiuk, Paolo Bruzzi, Liliana Varesco. Public Health Genomics 2015
16
100

Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
Kathleen Moore, Nicoletta Colombo, Giovanni Scambia, Byoung-Gie Kim, Ana Oaknin, Michael Friedlander, Alla Lisyanskaya, Anne Floquet, Alexandra Leary, Gabe S Sonke,[...]. N Engl J Med 2018
717
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.